Mahnaz Asgharnejad
- Medical Terminology top 2%
- Psychiatry and Mental health top 1%
- Migraine and Headache Studies 12
- Epilepsy research and treatment 8
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 20
- Neurological disorders and treatments 15
- Botulinum Toxin and Related Neurological Disorders 9
- Physiology top 5%
- Sympathectomy and Hyperhidrosis Treatments 6
-
- Pharmacological Effects and Toxicity Studies 7
-
- Neuroscience and Neuropharmacology Research 6
- Co-authors
- Antonio LaurenzaMargaret PeykamianA. David RothnerLars BauerPaul WinnerRobert NettRandall AustinJoel R. Saper
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Mahnaz Asgharnejad
63 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Medical Terminology 15
- Psychiatry and Mental health 894
- Neurology 511
- Pathology and Forensic Medicine 393
- Physiology 398
Countries citing papers authored by Mahnaz Asgharnejad
This map shows the geographic impact of Mahnaz Asgharnejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahnaz Asgharnejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahnaz Asgharnejad more than expected).
Fields of papers citing papers by Mahnaz Asgharnejad
This network shows the impact of papers produced by Mahnaz Asgharnejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahnaz Asgharnejad. The network helps show where Mahnaz Asgharnejad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mahnaz Asgharnejad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 15 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 34 | |
| 6 | 2023 | 13 | |
| 7 | 2021 | 40 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 26 | |
| 11 | 2018 | 14 | |
| 12 | 2017 | 18 | |
| 13 | 2016 | 13 | |
| 14 | 2016 | 8 | |
| 15 | 2016 | 46 | |
| 16 | 2014 | 10 | |
| 17 | 2014 | 10 | |
| 18 | 2013 | 2 | |
| 19 | 2003 | 34 | |
| 20 | 1995 | 89 |
About Mahnaz Asgharnejad
Mahnaz Asgharnejad is a scholar working on Psychiatry and Mental health, Neurology and Biological Psychiatry, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (15 papers), Migraine and Headache Studies (12 papers), Botulinum Toxin and Related Neurological Disorders (9 papers), Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Sympathectomy and Hyperhidrosis Treatments (6 papers). The work is most often cited by research in Medical Terminology (15 citations), Psychiatry and Mental health (894 citations) and Neurology (511 citations). Mahnaz Asgharnejad has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Antonio Laurenza, Margaret Peykamian, A. David Rothner, Lars Bauer, Paul Winner, Robert Nett, Randall Austin, Joel R. Saper, Paolo Barone and Angelo Antonini. Their work appears in journals such as PLoS ONE, Neurology and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.